U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232680) titled 'Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy' on Nov. 14.
Brief Summary: To prospectively investigate and integrate radiomic and immunologic signatures in patients with nasopharyngeal carcinoma (NPC) treated with either proton or photon radiotherapy, with the aim of identifying biomarkers associated with treatment response, toxicity, and long-term outcomes.
Study Start Date: Nov. 10
Study Type: OBSERVATIONAL
Condition:
NPC Patients
Nasopharyngeal Cancinoma (NPC)
Intervention:
RADIATION: Proton chemoradiotherapy
Concurrent chemoradiotherapy will be delivered ...